January 2025 $$ Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study
Journal: Lancet Psychiatry
Author: Dr. Susanne Meinert
Institution: Institute for Translational Psychiatry, University of Münster
December 2024 $$ Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Journal: New England Journal of Medicine
Author: Prof. Dr. Frederik Damm
Institution: Charité – Universitätsmedizin Berlin, Department of Hematology, Oncology and Cancer Immunology, Campus Virchowklinikum
November 2024: $$ Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients with Hodgkin Lymphoma
Journal: Journal of Clinical Oncology
Author: Jan-Michel Heger
Institution: Department I of Internal Medicine, University Hospital Cologne
October 2024: $$ Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4
Journal: Radiology
Author: Kai Roman Laukamp
Institution: Institute for Diagnostic and Interventional Radiology, University Hospital Cologne
August 2024: $$ STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
Journal: Cell 2024
Author: Marcel S. Woo
Institution: Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf
July 2024: $$ Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
Journal: Nature Cancer 2024
Authors: Erik Thiele Orberg und Elisabeth Meedt
Institution: Technische Universität München (ETO) und Universitätsklinikum Regensburg (EM)
June 2024: $$ Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes
Journal: Nature Medicine 2024
Author: Dr. Kami Pekayvaz
Institution: Medizinische Klinik I, LMU Klinikum
May 2024: $$ Multimodal layer modelling reveals in vivo pathology in amyotrophic lateral sclerosis
Journal: Brain 2024
Author: Esther Kühn
Institution: Hertie Institute for Clinical Brain Research
April 2024: $$ The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Journal: Nature Communications 2024
Author: Dr. Stephan Spahn
Institution: Department of Internal Medicine I, University Hospital Tuebingen
March 2024 $$ Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
Journal: Blood 2024
Author: Dr. Jan-Michel Heger
Institution: Klinik I für Innere Medizin, Uniklinik Köln